Skip to main content

BioVenture — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

279
Companies
$2.1B
Total invested
$23.9M
Avg. check
29
Industries
Biotechnology 16Health Care 16Medical 8Biopharma 7Life Science 6Therapeutics 6+23 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 73–96 of 279
Apexigen
January 2023

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Biopharma · San Carlos$2.8M Post-IPO Equity
Lipidio Pharmaceuticals
November 2022

Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.

Biopharma · San Diego$20.0M Series A
Gate Neurosciences
October 2022

Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.

Biotechnology · Carmel$25.0M Venture - Series Unknown
Mebias Discovery
September 2022

Mebias Discovery holds a game-changing platform to discover next generation.

Gaming · Philadelphia$631K Venture - Series Unknown
Tridek-One
September 2022

Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.

Biotechnology · Évry$16.0M Venture - Series Unknown
Regenacy Pharmaceuticals
August 2022

Regenacy Pharmaceuticals Provides Healthcare Services.

Biotechnology · Waltham$9.3M Series B
Stimdia Medical
July 2022

Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.

Health Care · Eagan$16.0M Series B
Axcynsis Therapeutics
May 2022

Tetris Therapeutics is a platform-based biotechnology company

Biopharma · Singapore$15.0M Seed
Engimmune Therapeutics
May 2022

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

Biotechnology · Basel$15.8M Seed
Pathware
April 2022

Pathware is creating hardware and software to simplify digital pathology workflows.

Computer · Golden$7.0M Series A
Freeline
March 2022

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Biopharma · Stevenage$26.1M Post-IPO Equity
Curbside Health
January 2022

Improving medical decision making through an EHR-integrated B2B SaaS platform for hospitals and front-line clinicians.

Electronic Health Record (EHR) · San Francisco$3.7M Seed
HotSpot Therapeutics
November 2021

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Biopharma · Boston$100.0M Series C
Treadwell Therapeutics
November 2021

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Biotechnology · New York$91.0M Series B
Tavotek Biotherapeutics
November 2021

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.

Biopharma · Gwynedd$35.0M Series B
eGlint
November 2021

Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.

Analytics · San Diego$2.4M Seed
DeepSight Technology
October 2021

DeepSight Technology's vision is to reinvent diagnostic imaging.

Medical Device · San Francisco$25.0M Series A
IpiNovyx Bio
October 2021

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

Biopharma · West Nyack$10.0M Seed
Renovacor
September 2021

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Biotechnology · Philadelphia$30.0M Post-IPO Equity
NeuralGalaxy
August 2021

NeuralGalaxy is a brain science company which is devoted to solve brain disorders.

Health Care · Boston$77.3M Series A
Tianhu Technology
March 2026

Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.

Alternative Protein · Minhang$29.0M Series A
AccuPulse
March 2026

AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters.

Health Care · Suzhou$14.5M Series B
Yili Pharmaceutical
March 2026

Yili Pharmaceutical is a pharmaceutical R&D company.

Biotechnology · Hangzhou$14.5M Seed
Lingchu Intelligence
March 2026

Lingchu is an embodied intelligence startup company that specializes in robot skill set training using reinforcement learning algorithms

Robotics · Haidian$290.4M Seed

Where BioVenture invests

Biotechnology16
Health Care16
Medical8
Biopharma7
Life Science6
Therapeutics6

About BioVenture's portfolio

How many companies has BioVenture invested in?▸

BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?▸

BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Life Science. The firm invests across 29 different industry categories.

What is BioVenture's largest investment?▸

Among tracked funding rounds, Lingchu Intelligence received $290.4M in a Seed round. BioVenture's total known invested capital is $2.1B.

What is the average investment size for BioVenture?▸

BioVenture's average investment size is $23.9M across its portfolio of 279 companies.

What are BioVenture's most recent investments?▸

Recent BioVenture portfolio additions include Apexigen, Lipidio Pharmaceuticals, Gate Neurosciences, Mebias Discovery, Tridek-One. These companies were founded in 2020 or later.

Reach the founders behind these 279 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →